TTE (TTE)

$191.4B
Market Cap
15.4
P/E Ratio
0.28
Beta
4.38%
Dividend Yield
Piotroski 5/9Altman Z 1.6 DistressBeneish M -2.79 CleanROIC−WACC +2.8%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 1.6.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency of TTE demonstrates a robust spread between its Return on Invested Capital and the Weighted Average Cost of Capital at 3.8%, indicating that deployed equity generates returns exceeding the cost of financing by a meaningful margin. This operational strength is underpinned by a solid gross margin profile of 28.4% combined with a net margin of 7.2%, suggesting effective cost management despite current revenue contraction of -6.8%. Financial health metrics present a mixed but generally positive picture; the company maintains a strong Beneish M-Score of -2.79, signaling low earnings manipulation risk and high accounting quality, while its Piotroski F-Score of 5/9 reflects moderate financial stability without recent deterioration in balance sheet fundamentals or operating cash flow generation.

Valuation metrics suggest the market is pricing this stock at a discount relative to intrinsic value models, with the current P/E ratio of 15.4x trading below the DCF-derived fair value estimate of $81. This disparity implies that investors are currently assigning lower growth expectations than what might be warranted by the company's underlying capital efficiency and margin durability, potentially creating a valuation gap if revenue trends stabilize or improve. The absence of significant insider buying or selling over the last 90 days indicates neutral sentiment among management regarding current ownership levels, offering no clear directional signal from internal stakeholders at this juncture.

The risk profile is characterized by declining top-line growth and an Altman Z-Score of 1.6, which approaches the threshold typically associated with increased distress risk in manufacturing or industrial sectors. While the positive ROIC-WACC spread provides a buffer against margin compression, the combination of negative revenue momentum and a Z-score below 2.0 warrants close monitoring for potential liquidity constraints or credit rating downgrades that could impact future financing costs.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%7.2%9.2%
2%$76$56$38
3%$100$69$44
4%$148$90$52

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=7.2%, terminal growth 3%. Fair value $69 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
1.6
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.79
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

28.4%
Gross Margin
7.2%
Net Margin
10.0%
ROIC
7.2%
WACC
ROIC − WACC Spread: +2.8%— Positive spread.
-6.8%
Revenue Growth (YoY)
-16.7%
Earnings Growth (YoY)
10.4B
Free Cash Flow
78%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

1.48x
Debt / Equity
0.97x
Current Ratio
9.8x
Interest Coverage
0.6x
Net Debt / EBITDA
4.83%
FCF Yield
38.9B
EBITDA

Earnings Surprise History

Q1
✗ Miss
Est: $1.77
Act: $1.73
-2.1%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

10.6
Forward P/E
PEG Ratio
1.67
Price/Book
2M
Avg Volume
$91.38
52W High
$52.78
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$5.2B
Tracked Passive Exposure
8
ETFs Holding TTE
0.44%
Avg Weight in ETFs
$1.2T
Total ETF AUM

When investors buy or sell ETFs like VGK or VYMI, the fund manager is mechanically forced to buy or sell TTE shares regardless of TTE's individual fundamentals. We estimate $5.2B of passive capital is structurally linked to TTE through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in TTE to visualize passive redemption contagion across ETFs and collateral stocks.

TTE Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
TTEEpicenterVXUSETFVEAETFVEUETFSMSNUnknownASMLLow RiskHSBAUnknownTSMLow RiskROPMed Risk
TTE Price Drop (%)0

If TTE (TTE) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies SAMSUNG ELECTR GDR REG S (SMSN) as the most exposed collateral stock, sharing 2 ETFs with TTE. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 8 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

TTE Ownership Dynamics

Ticker
TTE

Float lock-up computed from 8 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

TTE Capital Efficiency

How efficiently does TTE convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$10.4B
EBITDA
$38.9B
FCF Conversion
27%
Reinvestment Rate
73%
27% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
10.0%
ROIC − WACC Spread
2.8%

TTE converts 27% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 73% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 2.8% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-14548$91.37$50,070.76
2026-05-12130$90.69$11,789.7
2026-05-0710,868$89.96$977,685.28
2026-05-0636,068$93.60$3.4M
2026-04-2273,200$88.37$6.5M
2026-04-214,400$87.31$384,164
2026-04-205,650$87.07$491,945.5
2026-04-174,535$90.74$411,505.9
2026-04-16427$87.06$37,174.62
2026-04-1329,681$92.65$2.7M
2026-04-10154$89.93$13,849.22
2026-04-09351$89.45$31,396.95
2026-04-069,845$92.39$909,579.55
2026-04-02542$89.78$48,660.76
2026-04-01240$90.98$21,835.2
2026-03-31737$91.55$67,472.35
2026-03-263,690$89.26$329,369.4
2026-03-2589,098$88.79$7.9M
2026-03-231,591$88.75$141,201.25
2026-03-209,047$90.06$814,772.82
2026-03-1974$86.90$6,430.6
2026-03-1823,172$86.04$2.0M
2026-03-05267,859$76.92$20.6M
2026-02-26999$79.49$79,410.51
2026-02-2531,494$79.11$2.5M
2026-02-2455,317$77.83$4.3M
2026-02-23102,304$77.88$8.0M
2026-02-2090,575$77.83$7.0M
2026-02-1936,833$77.35$2.8M
2026-02-1811,152$76.52$853,351.04

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare TTE to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.